Diamidines for human African trypanosomiasis

被引：0

作者：

Paine, Mary F. ^{[2
,3
]}

Wang, Michael Zhuo ^{[2
,3
]}

Generaux, Claudia N. ^{[2
,3
]}

Boykin, David W. ^{[4
]}

Wilson, W. David ^{[4
]}

De Koning, Harry P. ^{[1
]}

Olson, Carol A. ^{[5
]}

Pohlig, Gabriele ^{[6
,7
]}

Burri, Christian ^{[6
,7
]}

Brun, Reto ^{[6
,7
]}

Murilla, Grace A. ^{[8
]}

Thuita, John K. ^{[8
]}

Barrett, Michael P. ^{[1
]}

Tidwell, Richard R. ^{[2
,3
]}

机构：

[1] Univ Glasgow, Wellcome Trust Ctr Mol & Biochem Parasitol, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland

[2] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA

[3] Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA

[4] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA

[5] Sapphire Oak Consultants, Lindenhurst, IL 60046 USA

[6] Swiss Trop & Publ Hlth Inst, Dept Pharmaceut Med, CH-4051 Basel, Switzerland

[7] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol, CH-4051 Basel, Switzerland

[8] Trypanosomiasis Res Ctr, Kenya Agr Res Inst, Kikuyu, Kenya

来源：

CURRENT OPINION IN INVESTIGATIONAL DRUGS | 2010年 / 11卷 / 08期

关键词：

Blood-brain barrier; clinical trial; diamidine; drug metabolism; drug transport; furamidine; human African trypanosomiasis; pentamidine; sleeping sickness; SUBSTRATE RECOGNITION MOTIFS; ANTIPROTOZOAL ACTIVITY; PURINE TRANSPORTER; RNA-INTERFERENCE; PRODRUG DB289; AZA-ANALOGS; BRUCEI; PENTAMIDINE; RESISTANCE; AFFINITY;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS. A major research effort to design novel diamidines has led to the development of orally active prodrugs and, remarkably, a new generation of compounds that can penetrate the CNS. In this review, progress in the development of diamidines for the treatment of HAT is discussed.

引用

页码：876 / 883

页数：8

共 50 条

[1] PROSPECTS OF USE OF THE ERLANGEN DIAMIDINES IN THE TREATMENT OF ANIMAL AND HUMAN TRYPANOSOMIASIS
BAFORT, JM
[J]. ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1985, 65 (04): : 412 - 413
[2] Human African trypanosomiasis
Kioy, D
Jannin, J
Mattock, N
[J]. NATURE REVIEWS MICROBIOLOGY, 2004, 2 (03) : 186 - 187
[3] Human African trypanosomiasis
Buscher, Philippe
Cecchi, Giuliano
Jamonneau, Vincent
Priotto, Gerardo
[J]. LANCET, 2017, 390 (10110): : 2397 - 2409
[4] Human African trypanosomiasis
Brun, Reto
Blum, Johannes
Chappuis, Francois
Burri, Christian
[J]. LANCET, 2010, 375 (9709): : 148 - 159
[5] Human African trypanosomiasis
Stich, A
Abel, PM
Krishna, S
[J]. BRITISH MEDICAL JOURNAL, 2002, 325 (7357): : 203 - 206
[6] Human African Trypanosomiasis
Brun, Reto
Blum, Johannes
[J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (02) : 261 - +
[7] Human African trypanosomiasis
Kennedy, P. G. E.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 305 - 305
[8] Conflict and human African trypanosomiasis
Berrang-Ford, Lea
Lundine, Jamie
Breau, Sebastien
[J]. SOCIAL SCIENCE & MEDICINE, 2011, 72 (03) : 398 - 407
[9] Epidemiology of human African trypanosomiasis
[J]. CONTROL AND SURVEILLANCE OF HUMAN AFRICAN TRYPANOSOMIASIS, 2013, 984 : 3 - 41
[10] THE TREATMENT OF HUMAN AFRICAN TRYPANOSOMIASIS
PEPIN, J
MILORD, F
[J]. ADVANCES IN PARASITOLOGY, VOL 33, 1994, 33 : 1 - 47

← 1 2 3 4 5 →